Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
{{output}}
Pancreatic cancer is an aggressive malignancy with increasing incidence. Pancreatic ductal adenocarcinoma (PDAC) accounts for > 90% of pancreatic cancer diagnoses, while other exocrine tumors are much rarer. In this review, we have focused on two rare cancers ... ...
